Biomarkers of liver failure in obstructive jaundice as preclinical indicators reflecting the development of the pathological process
Journal of Clinical Practice · 15.11.2026 · 17 (3) · 114-124
DOI: 10.17816/clinpract692106 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Practice, online erschienen am 15.11.2026. Verfasst von Irina V. Mamoshina und 3 weiteren Autor:innen. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Liver failure due to mechanical jaundice is a pressing issue for intensive care. The main goals of treatment are to restore and maintain liver function, prevent or minimize the development of secondary complications in organs and systems. Traditionally, a range of different methods is used in the diagnosis of mechanical jaundice-caused liver failure, ranging from instrumental, biochemical, serological, immunological, to the most complex molecular biological studies. However, generally accepted indicators do not always reflect the depth of damage to the liver parenchyma and the severity of the pathological process, which requires a search for specific markers of liver damage as indicators of the severity of the patient's condition and predictors of the outcome of the disease. Potential candidate markers should have high topical diagnostics efficacy, specificity and sensitivity in the first hours of the disease. According to the literature, the following biomarkers of liver injury potentially meet these requirements: liver form of fatty acid binding protein, 5-nucleotidase, liver arginase, and hyaluronic acid. However, the reliability of these markers for assessing patient status and predicting outcomes of liver failure in mechanical jaundice remains insufficiently studied and requires further research.
Zitieren
APA
Mamoshina, I. V., Petrova, M. V., Mamoshin, A. V., & Kuzin, A. P. (2026). Biomarkers of liver failure in obstructive jaundice as preclinical indicators reflecting the development of the pathological process. Journal of Clinical Practice, 17(3), 114-124. https://doi.org/10.17816/clinpract692106
Vancouver
Mamoshina IV, Petrova MV, Mamoshin AV, Kuzin AP. Biomarkers of liver failure in obstructive jaundice as preclinical indicators reflecting the development of the pathological process. Journal of Clinical Practice. 2026;17(3):114-124. doi:10.17816/clinpract692106
BibTeX
@article{Mamoshina2026,
author = {Mamoshina, Irina V. and Petrova, Marina V. and Mamoshin, Andrian V. and Kuzin, Alexander P.},
title = {Biomarkers of liver failure in obstructive jaundice as preclinical indicators reflecting the development of the pathological process},
journal = {Journal of Clinical Practice},
year = {2026},
volume = {17},
number = {3},
pages = {114--124},
doi = {10.17816/clinpract692106}
}
EUVIMED